date:May 08, 2012
on and Sandy Shaw), which validated them as a First Amendment freedom of speech right.
The claims enable firms to talk about a relationship between a substance and disease where the supporting science fails to meet the FDAs significant scientific agreement standard, but is qualified in such a way as to not mislead consumers.
While the qualification comes in the form of a far-from-consumer-friendly disclaimer, many observers believe the claims are still better than nothing.